Mental deterioration correlates with response of natural killer (NK) cell activity to physiological modifiers in patients with short history of Alzheimer's disease

Psychoneuroendocrinology

Volumn 27, Issue 4, 2002, Pages 447-461

  Masera, Rosa Gabriella ^a   Prolo, Paolo ^c   Sartori, Maria Luisa ^a   Antonio Staurenghi, ^a   Griot, Giulietta ^a   Ravizza, Luigi ^b   Dovio, Andrea ^a   Chiappelli, Francesco ^c   Angeli, Alberto ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b UNIVERSITY OF TURIN   (Italy)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cortisol; Cytokines; Dementia; DHEA; NK cell activity; POMC derived peptides

Indexed keywords

ANDROGEN; BETA ENDORPHIN; CORTICOTROPIN; CORTICOTROPIN RELEASING FACTOR RECEPTOR; CYTOKINE; HYDROCORTISONE; PEPTIDE DERIVATIVE; PRASTERONE; PROOPIOMELANOCORTIN; RECOMBINANT GAMMA INTERFERON; RECOMBINANT INTERLEUKIN 2;

AGED; ALZHEIMER DISEASE; ANAMNESIS; ARTICLE; CELL ACTIVITY; CLINICAL ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; CYTOTOXICITY; DISEASE COURSE; DISEASE SEVERITY; ENDOCRINE FUNCTION; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; IN VITRO STUDY; INHIBITION KINETICS; MALE; MENTAL DETERIORATION; MONONUCLEAR CELL; NATURAL KILLER CELL; PRIORITY JOURNAL; PROGNOSIS; RATING SCALE; SENILE DEMENTIA;

AGED; ALZHEIMER DISEASE; CYTOKINES; CYTOTOXICITY, IMMUNOLOGIC; DEHYDROEPIANDROSTERONE; DISEASE PROGRESSION; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; KILLER CELLS, NATURAL; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDES; PITUITARY-ADRENAL SYSTEM; PRO-OPIOMELANOCORTIN; PROGNOSIS;

EID: 0036127630     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(01)00062-2     Document Type: Article

References (45)

1. Chronobiological aspects of the neuroendocrine-immune network. Regulation of human natural killer (NK) cell activity as a model
2. Reduced natural killer cell activity in patients with dementia of Alzheimer type
3. Immuno-neuroendocrine interactions: Facts and hypotheses
4. Allopregnanolone and dehydroepiandrosterone response to corticotropin releasing factor in patients suffering from Alzheimer's disease and vascular dementia
5. Effects of IL-12 on immune responses to microbial infections: A key mediator in regulating disease outcome
6. Pro-opiomelanocortin and the immune-neuroendocrine connection
7. Isolation of lymphocytes, granulocytes and macrophages. Mononuclear cells and granulocytes from human blood
8. Expression of pro-opiomelanocortin gene and quantification of adrenocorticotropin hormone-like immunoreactivity in human normal peripheral mononuclear cells and lymphoid and myeloid malignancies
9. Current concepts in the pathogenesis of Alzheimer's disease
10. Differential regulation of three human cytotoxic cell populations by β-endorphin
11. Neuroendocrine modulation of the immune system
12. Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia
13. Mìnì-mental state. A practical method for grading the cognitive state of patients for the clinician
14. Peripheral markers in testing pathophysiological hypotheses and diagnosing Alzheimer's disease
15. Interplay in vitro between ACTH, β-endorphin, and glucocorticoids in the modulation of spontaneous and lymphokine-inducible human natural killer (NK) cell activity
16. A new rating scale for dementia syndromes
17. A rating scale for depression
18. Neurosteroids, brain damage, and mental illness
19. Interperson variability but intraperson stability of baseline plasma cortisol concentrations, and its relation to feedback sensitivity of the hypothalamo-pituitary-adrenal axis to a low dose of dexamethasone in elderly individuals
20. Activation of immune function by dehydroepiandrosterone (DHEA) in age-advanced men
21. An enzyme release assay for natural cytotoxicity
22. DHEA and DHEA-S: A review
23. Antiglucocorticoid function of androstenetriol
24. Neuroprotection by dehydroepiandrosterone-sulfate: Role of NFkB-like factor
25. Dementia of the Alzheimer type and hypothalamus-pituitary-adrenocortical axis: Changes in cerebrospinal fluid corticotropin releasing factor and plasma cortisol levels
26. Natural Killer (NK) cell activity in Cushing's syndrome
27. Clinical diagnosis of AIzheimer's disease: Report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease
28. Effects of replacement dose of dehydroepiandrosterone in man and women of advancing age
29. Relationships between cortisol, dehydroepiandrosterone sulphate and insulin-like growth factor-I system in dementia
30. Lymphocyte-derived adrenocorticotropin is insufficient to stimulate adrenal steroidogenesis in hypophysectomized rats
31. Spontaneous human lymphocyte-mediated citotoxicity against tumor target cells. IX. The quantitation of human natural killer cell activity
32. Adrenal responsivity in normal aging and mild to moderate Alzheimer's disease
33. The globaI deterioration scale for assessment of primary degenerative dementia
34. Effects of dehydroepiandrosterone and its sulphate on brain tissue in culture and on memory in mice
35. Natural killer cells and natural killer T cells
36. Aging and hypothalamic-pituitary-adrenal response to challenge in humans
37. Corticotropin-releasing factor induction of leukocyte derived immunoreactive ACTH and endorphins
38. Dehydroepiandrosterone sulphate decreases the interleukin-2-mediated overactivity of the natural killer cell compartment in senile dementia of the Alzheimer type
39. Hypothalamic-pituitary-adrenal axis function, psychopathological traits, and natural killer (NK) cell activity in anorexia nervosa
40. Dehydro-epiandrosterone and ageing
41. Hypothalamic-pituitary-adrenal axis dysfunction in Alzheimer's disease: Lack of association between longitudinal and cross-sectional findings
42. Biology of natural killer cells
43. Cortisol secretion and Alzheimer's disease progression
44. Interleukin 12: A key modulator of immune function
45. Double-blind treatment of major depression with dehydroepiandrosterone